Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    April 2022
  1. CHAI Y, Chen B, Qi F, Fang H, et al
    First-line chemoradiation with or without chidamide (tucidinostat) in patients with early stage intermediate- and high-risk early-stage extranodal nasal-type natural killer/T-cell lymphoma: a randomized phase 2 study in China.
    Int J Radiat Oncol Biol Phys. 2022 Apr 19. pii: S0360-3016(22)00312.
    PubMed     Abstract available


    February 2022
  2. LADBURY C, Kambhampati S, Othman T, Hao C, et al
    Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post Autologous Stem Cell Transplant.
    Int J Radiat Oncol Biol Phys. 2022 Feb 14. pii: S0360-3016(22)00161.
    PubMed     Abstract available


    January 2022
  3. SHER DJ
    Fifty Shades of GyE: Interpreting the Cost-Effectiveness of Proton Beam Therapy for Mediastinal Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2022;112:167-168.
    PubMed    


    December 2021
  4. YEOH KW, Yong FY
    Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
    PubMed    


  5. THOMAS HR, Yom SS
    Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
    PubMed    


  6. WU SY, Pinnix CC
    Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL.
    Int J Radiat Oncol Biol Phys. 2021;111:1105-1106.
    PubMed    


  7. YANG Y
    Short-Course Induction Chemotherapy Followed by Radiotherapy is the Effective Strategy for Intermediate-Risk/High-Risk Early-Stage ENKTCL.
    Int J Radiat Oncol Biol Phys. 2021;111:1103.
    PubMed    


  8. FIGURA NB, Robinson TJ, Sim AJ, Wang X, et al
    Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:1145-1154.
    PubMed     Abstract available


    November 2021
  9. MILGROM SA, Bakst RL, Campbell BA
    Clinical Outcomes Confirm Conjecture: Modern Radiation Therapy Reduces the Risk of Late Toxicity in Survivors of Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:841-850.
    PubMed    


  10. PARIKH RR, Kelly KM, Hodgson DC, Hoppe BS, et al
    Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (XXXX): A Report from the Children's Oncology Group.
    Int J Radiat Oncol Biol Phys. 2021 Nov 9. pii: S0360-3016(21)03075.
    PubMed     Abstract available


  11. NTENTAS G, Dedeckova K, Andrlik M, Aznar MC, et al
    Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
    Int J Radiat Oncol Biol Phys. 2021 Nov 8. pii: S0360-3016(21)03074.
    PubMed     Abstract available


  12. PLASTARAS JP, Svoboda J
    PET/CT Responses in Primary Mediastinal Large B-Cell Lymphoma: What's Negative?
    Int J Radiat Oncol Biol Phys. 2021;111:595-596.
    PubMed    


  13. KRAUS R, Tao R
    To Radiate or Not to Radiate? Implications of PET Biomarkers in Primary Mediastinal B-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:594.
    PubMed    


  14. ANDERSON G, Shinde A
    Primary Mediastinal B-Cell Lymphoma: The Role of Consolidative Radiation for a "Terrible" Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:592-593.
    PubMed    


  15. PATEL AM, Ali O, Kainthla R, Rizvi S, et al
    Primary CNS Lymphoma: Comparison of Outcomes and the Use of Radiation Therapy in Patients Treated at a Public Safety Net Hospital vs. a Tertiary Academic Center.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  16. VASILIADOU I, Mikhaeel G, Brady JL, Poetter V, et al
    Factors Affecting Outcome of Bridging Radiotherapy (RT) Before CAR-T for High Grade Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  17. GRIFFITH T, Parsons MW, Tward JD, Tao R, et al
    Risk of Secondary Breast Cancer in Female Non-Hodgkin Lymphoma Survivors: 40 Years of Follow-Up Assessed by Treatment Modality.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  18. WRIGHT CM, Baron J, Lee DY, Carpenter M, et al
    Disease Outcomes Following Low-Dose Radiotherapy vs. Moderate-Dose Radiotherapy for Orbital Low Grade Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  19. KIM JK, Zhang JY, Wang W, McCarthy A, et al
    A Dosimetric Comparison of IMRT and 3D-CRT Using Deep Inspiratory Breath Hold (DIBH) and Free-Breathing (FB) Techniques in Gastric Mucosa Lymphoid Tissue Lymphoma (MALT).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  20. RAVELLA R, Zhang-Velten ER, Awan F, Rizvi S, et al
    Analysis of Patterns of Failure and the Role of Bridging Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Treated with CAR T-Cell Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  21. MANJUNATH SH, Larose MI, Carpenter M, Svoboda J, et al
    Radiation Therapy (RT)-Based Salvage Therapy for Classical Hodgkin Lymphoma (cHL).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  22. CHAMBERLIN HC, Astley S, Cowan R, Hague C, et al
    Breast Dose in Young Women Treated for Hodgkin Lymphoma Between 2007 and 2018: A Single Institutional Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  23. ZHANG YT, Li N, Wang JJ, Li YM, et al
    Association of B Symptoms With Plasma EBV-DNA Copy Number and Cytokine Profiles in Patients With Nasal Type Extranodal Natural Killer/T-Cell Lymphoma (ENKTL): A Mechanism and Prognostic Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  24. KINSLOW CJ, Krishnamurthy PB, Sanchez GI, Wang TJC, et al
    Risk of Anaplastic Large Cell Lymphoma After Post-Mastectomy Implant-Reconstruction for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  25. ZHENG X, He X, Yang Y, Qi SN, et al
    Improved Overall Survival Associated With Decreased Distant Metastasis Following Asparaginase-Based Chemotherapy and Radiotherapy for Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  26. MILLIGAN MG, Chukwueke UN, Fisher DC, Ng AK, et al
    Stereotactic Radiation Therapy With Concurrent Immune Checkpoint Inhibitor Therapy in Patients With Relapsed or Refractory Central Nervous System Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  27. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-Based Study on the Association Between Autoimmune Disease and Lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  28. SAKTHIVEL G, Chowdhry AK, Milano MT
    Second Primary Urinary Cancer in Hodgkin Lymphoma Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  29. ROCK CB, Parsons MW, Chipman J, Shah H, et al
    Secondary Malignancies in Diffuse Large B-cell Lymphoma Survivors With 40 Years of Follow-Up: Influence of Chemotherapy and Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  30. MILGROM SA, Kim J, Hoppe BS, Pei Q, et al
    PET-Based Quantification of Baseline Metabolic Tumor Burden Improves Risk Stratification in High-Risk Hodgkin Lymphoma: A Children's Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  31. COUTU BG, Lawrence E, Bociek G, Armitage J, et al
    Consolidative Radiotherapy Remains a Key Player in the Salvage Management of Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  32. SAIFI O, Breen W, Lester SC, Rule WG, et al
    Radiation Therapy as Bridging Treatment to CAR T Cell Therapy in Non-Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  33. BREEN W, Hathcock M, Young JR, Stish BJ, et al
    Metabolic Kinetics of Non-Hodgkin Lymphoma Prior to CAR-T Infusion: Prognostic Factors and Risk Stratification.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  34. KUHNL A, Mikhaeel G, Kirkwood AA, Menne TF, et al
    Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  35. URBAN R, Chow R, Pickles T, Chan M, et al
    The Impact of Surveillance Imaging After Curative Intent Radiotherapy for Limited Stage Follicular Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  36. MACMANUS MP, Roos DE, O'Brien P, Anne C, et al
    Prospective Phase II Trial of Radiation Therapy in Localized Non-Gastric Marginal Zone Lymphoma With Evaluation of Autoimmunity and Helicobacter Pylori Status.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  37. KHAN MK, Mourad WF
    Biopsy, as Deauville May Deceive.
    Int J Radiat Oncol Biol Phys. 2021;111:594-595.
    PubMed    


    August 2021
  38. HALL MD, Terezakis SA, Lucas JT Jr, Gallop-Evans E, et al
    Radiotherapy across pediatric Hodgkin lymphoma research group protocols: a report from the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) Group.
    Int J Radiat Oncol Biol Phys. 2021 Aug 11. pii: S0360-3016(21)02629.
    PubMed     Abstract available


  39. BAUES C, Goergen H, Fuchs M, Rosenbrock DJ, et al
    Involved-Field Radiotherapy prevents recurrences in the early stages of Hodgkin's lymphoma in PET-negative patients after ABVD Chemotherapy Relapse Analysis of GHSG Phase III HD16 Trial.
    Int J Radiat Oncol Biol Phys. 2021 Aug 10. pii: S0360-3016(21)02599.
    PubMed     Abstract available


  40. VEGA RBM, Mohammadi H, Patel SH, Md ALH, et al
    Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma.
    Int J Radiat Oncol Biol Phys. 2021 Aug 1. pii: S0360-3016(21)02624.
    PubMed     Abstract available


    March 2021
  41. HOPPE BS, Advani R, Milgrom SA, Bakst RL, et al
    Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society(TM) Appropriate Use Criteria.
    Int J Radiat Oncol Biol Phys. 2021 Mar 24. pii: S0360-3016(21)00295.
    PubMed     Abstract available


    February 2021
  42. QI SN, Li YX, Specht L, Oguchi M, et al
    Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2021 Feb 10. pii: S0360-3016(21)00186.
    PubMed     Abstract available


    December 2020
  43. MOU E, Advani RH, von Eyben R, Rosenberg SA, et al
    Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies).
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34735.
    PubMed     Abstract available


  44. FANG P, Gunther JR, Pinnix CC, Dong W, et al
    A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Dec 9. pii: S0360-3016(20)34644.
    PubMed     Abstract available


  45. SPECHT L, Wong JYC, Filippi AR, Dabaja BS, et al
    In Reply to Scarpelli et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1396.
    PubMed    


  46. SCARPELLI DB, Murphy B, Chang BH, Nemecek E, et al
    In Regard to Wong et al.
    Int J Radiat Oncol Biol Phys. 2020;108:1395-1396.
    PubMed    


    November 2020
  47. PATEL R, Zhang L, Desai A, Hoenerhoff MJ, et al
    Protons and High-Linear Energy Transfer Radiation Induce Genetically Similar Lymphomas With High Penetrance in a Mouse Model of the Aging Human Hematopoietic System.
    Int J Radiat Oncol Biol Phys. 2020;108:1091-1102.
    PubMed     Abstract available


    October 2020
  48. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed     Abstract available


  49. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


    August 2020
  50. TSENG YD, Hoppe BS, Dedeckova K, Patel CG, et al
    Risk of pneumonitis and outcomes after mediastinal proton therapy for relapsed/refractory lymphoma: A PTCOG and PCG collaboration.
    Int J Radiat Oncol Biol Phys. 2020 Aug 28. pii: S0360-3016(20)34202.
    PubMed     Abstract available


  51. DABAJA BS, Ng AK, Terezakis SA, Plastaras JP, et al
    ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Aug 4. pii: S0360-3016(20)31365.
    PubMed    


    July 2020
  52. DABAJA B, Milgrom S, Parikh R, Wu S, et al
    The Challenges of Applying Radiation in Primary Central Nervous System Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020;107:398-400.
    PubMed    


  53. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    PubMed    


  54. PARIKH RR
    More Is Better, Especially When Radiation Is the Best Option....
    Int J Radiat Oncol Biol Phys. 2020;107:402-403.
    PubMed    


  55. MILGROM SA
    Striking a Delicate Balance: Disease Control Without Neurotoxicity.
    Int J Radiat Oncol Biol Phys. 2020;107:401.
    PubMed    


    May 2020
  56. WRIGHT CM, LaRiviere MJ, Baron JA, Uche C, et al
    Bridging Radiation Therapy Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for relapsed/refractory aggressive B-cell lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 May 21. pii: S0360-3016(20)31138.
    PubMed     Abstract available


  57. PATEL CG, Ng AK
    Involved-Site Radiation Therapy for Early-Stage NLPHL.
    Int J Radiat Oncol Biol Phys. 2020;107:21-22.
    PubMed    


  58. GUNTHER JR
    Involved-Site Radiation Therapy if Minimal Toxicity.
    Int J Radiat Oncol Biol Phys. 2020;107:20-21.
    PubMed    


  59. BUDNIK J, Suri J, Constine LS
    A (Sub)Mental Challenge.
    Int J Radiat Oncol Biol Phys. 2020;107:18-19.
    PubMed    


    April 2020
  60. WIRTH A, Mikhaeel NG, Pauline Aleman BM, Pinnix CC, et al
    Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.
    Int J Radiat Oncol Biol Phys. 2020 Apr 6. pii: S0360-3016(20)30943.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: